Environmental, Social & Governance Report 2023

"Amgen's commitment to good ESG practices dates back to our founding more than four decades ago. Throughout our history, Amgen has contributed to society in many ways – most importantly by bringing innovative medicines to patients with serious disease, but also by supporting our employees and their families, contributing to the well-being of our local communities, and operating our business in an ethical, environmentally responsible, and socially inclusive manner."

— Robert A. Bradway, Chairman and Chief Executive Officer

Healthy People

We focus on removing barriers that limit access to healthcare so that people can live their healthiest lives.

Focus Areas:

Provided $2.5 billion of qualifying Amgen medicines at no cost to eligible uninsured or underinsured patients in the United States through the Amgen Safety Net Foundation.¹
Launched a five-year program with World Child Cancer to improve the lives of children with Burkitt lymphoma.
Held our first Health Equity Challenge to support community-based nonprofit organizations that are advancing solutions to improve the health of patients with cardiovascular disease in Black communities.

Healthy Society

We focus on building a more resilient and inclusive society within our own workplace and in the communities where we operate.

Focus Areas:

Of employees who responded to our Global Engagement Survey, 79% reported that they would recommend Amgen as a great place to work.²
Welcomed our first "earn-and-learn" apprentices and launched the Amgen Career Re-entry Program.
Announced a new $12.4 million commitment to reach 180,000 more students through the Amgen Biotech Experience.

Healthy Planet

We prioritize sustainability and aim to minimize our environmental impact to preserve natural resources for generations to come.

Focus Areas:

We are on track to achieve our 2027 environmental sustainability goals and, as of the end of 2023, achieved 54% of our targeted reduction for carbon, 34% of our targeted reduction for water and 54% of our targeted reduction for waste disposed.³
Our biomanufacturing facility licensed by the U.S. FDA in 2024 and recently opened in Ohio was built to LEED Gold standards, and a second plant under construction in North Carolina is following its lead.
We formalized our expectations for engaging with suppliers within select spend categories to support their adoption of science-based climate targets.

A Healthy Amgen

We hold ourselves to high standards in our operations and continually strive to reflect Amgen values in our culture, products and strategy.

Focus Areas:

100% of employees have been trained on Amgen Code of Conduct.
We established the Amgen AI Governance Council and adopted the Trustworthy AI framework to promote responsible use of AI.
Leaders and their teams have access to a range of resources designed to facilitate open communication between staff and their managers.

¹Amgen Safety Net Foundation is a separate legal entity funded by Amgen. Valued at wholesale acquisition cost.
²Approximately 69% of employees who received the Global Engagement Survey responded.
³Water and waste reductions are measured against a 2019 baseline and take into account only verified reduction projects and not changes associated with the contraction or expansion of the Company.

We value and welcome feedback about ESG at Amgen.
Please contact us at ESG@amgen.com